DCGI

New Delhi: Drugs Controller General of India (DCGI) has given Cipla approval to import Moderna's COVID-19 vaccine for restricted emergency use in the country. Moderna’s COVID-19…

World Health Organization (WHO) cited insufficient data in rejecting the proposal of Serum Institute of India (SII), seeking extension of shelf life of Oxford-AstraZeneca’s COVID-19 vaccine,…

New Delhi: Pfizer has decided to withdraw the application for emergency use authorisation of its COVID-19 vaccine in India, the pharmaceutical major said on Friday. Incidentally, the US…

Mumbai: The debate over Bharat Biotech-manufactured Covaxin continues. A writ plea has been moved before the Bombay High Court seeking direction to the Drugs Controller General of India…

New Delhi: The Drugs Controller General of India (DCGI) has approved Bharat Biotech's Covaxin for children above the age of 12 years while Oxford-AstraZeneca's vaccine Covishield,…

New Delhi: The All India Drug Action Network (AIDAN) has urged the Drugs Controller General of India (DCGI) to reconsider the recommendations of the SEC in granting the REU approval to…

New Delhi: Lauding the final approval of the Drugs Controller General of India (DCGI) on Sunday to two COVID-19 vaccines, All India Institute Of Medical Science (AIIMS) Director Randeep…

New Delhi: The new year couldn't have begun on a better note for Pune-based Serum Institute Of India (SII) with Covishield getting the nod for restricted emergency use in India after the…

New Delhi: India has finally got its vaccine against coronavirus. Two vaccines — Pune-based Serum Institute’s Covishield and Bharat Biotech's Covaxin — received emergency use approval from…

New Delhi: The All India Drug Action Network (AIDAN) has asked the Drugs Controller General of India (DCGI) to reconsider SEC recommendation in granting REU approval to Bharat…